VEGFC Rabbit Polyclonal Antibody
CAT#: TA321716
Anti-VEGFC Rabbit Polyclonal Antibody
Size: 25 ul
Need it in bulk or conjugated?
Get a free quote
CNY 1,999.00
CNY 3,280.00
Cited in 2 publications. |
CNY 3,080.00
CNY 300.00
CNY 1,430.00
Specifications
Product Data | |
Applications | IHC, WB |
Recommend Dilution | WB: 200-1000 WB positive control: 231 cells IHC: 10-50 Positive control: Human ovarian cancer Predicted cell location: Cytoplasm |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Synthetic peptide corresponding to a region derived from 256-270 amino acids of human vascular endothelial growth factor C |
Formulation | PBS pH7.3, 0.05% NaN3, 50% glycerol |
Concentration | lot specific |
Purification | Antigen affinity purification |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 46 kDa |
Gene Name | vascular endothelial growth factor C |
Database Link | |
Background | The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family; is active in angiogenesis and endothelial cell growth; and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation; generating multiple processed forms which bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor D. |
Synonyms | Flt4-L; LMPH1D; VRP |
Reference Data | |
Protein Families | Druggable Genome, Secreted Protein |
Protein Pathways | Bladder cancer, Cytokine-cytokine receptor interaction, Focal adhesion, mTOR signaling pathway, Pancreatic cancer, Pathways in cancer, Renal cell carcinoma |
Citations (2)
The use of this Antibodies has been cited in the following citations: |
---|
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
,null,
OncoTargets and therapy
,PubMed ID 31354297
[VEGFC]
|
Expression of hepatocyte growth factor and c-Met in non-small-cell lung cancer and association with lymphangiogenesis.
,null,
Molecular medicine reports
,PubMed ID 25504327
[VEGFC]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |